XML 23 R10.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue
6 Months Ended
Jun. 30, 2024
Revenue  
Revenue

3.           Revenue

The Company recognized $4,000 and $33,000 of revenue for the three and six months ended June 30, 2024 respectively. This revenue is related to recovery of clinical manufacturing costs associated with an investigator sponsored study managed by Cedar-Sinai Medical Center. Revenues recognized for both the three and six months ended June 30, 2023 were $373,000.